HLIB raises Sunway Healthcare earnings forecasts after strong results

KUALA LUMPUR: Hong Leong Investment Bank Bhd (HLIB) Research raised its earnings forecasts for Sunway Healthcare Holdings Bhd by 8.8 per cent, 12.2 per cent and 12.5 per cent for financial years 2026 to 2028, respectively, following its recent stronger-than-expected results.
The revisions reflect higher revenue assumptions and a lower core effective tax rate, HLIB Research said in a note.
The research firm also raised its target price for Sunway Healthcare to RM2.20 from RM2.05, while maintaining its "Hold" call on the stock.
The revised target price is based on an unchanged 30 times financial year 2027 enterprise value-to-earnings before interest, taxes, depreciation and amortisation valuation multiple.
HLIB Research said the implied upside to the revised target price remained below 10 per cent, insufficient to warrant a more constructive stance at current levels.
"Sunway Healthcare reported third-quarter financial year 2026 core profit after tax and minority interests (Patmi) of RM102.9 million, up 24.9 per cent quarter-on-quarter (QoQ).
"The results came in above both our 75 per cent and consensus 78 per cent full-year estimates," it said.
HLIB Research said the stronger performance was driven by higher-than-expected revenue, underpinned by resilient domestic demand, alongside a more favourable core effective tax rate.
Revenue increased 9.6 per cent QoQ, supported by broad-based growth in patient activity across inpatient, outpatient and daycare services.
Inpatient revenue grew 12.1 per cent, outpatient revenue rose 4.3 per cent, while daycare revenue increased 6.7 per cent.
Foreign patient revenue also improved, rising 7.4 per cent to RM91.2 million from RM84.9 million previously, supported by seasonal tailwinds.
Core Patmi grew 24.9 per cent QoQ, reflecting favourable operating leverage at Sunway Medical Centre (SMC) Velocity and SMC Penang, alongside contributions from SMC Damansara and SMC Ipoh.
HLIB Research said SMC Ipoh's incremental contribution, following the commencement of operations in April 2025, further supported topline growth.
Looking ahead, HLIB Research expects stronger QoQ revenue in the fourth quarter, driven by growing contributions from SMC Damansara and SMC Ipoh as both facilities gain further traction.
It also expects Ebitda margins to expand further, supported by favourable operating leverage across hospitals and seasonal tailwinds.
The research firm added that the fourth quarter delivered stronger margins in the private hospital sector, reflecting a more favourable mix of elective surgeries.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.